Resources Contact Us Home
Ribonucleotide reductase inhibitors and methods of use

Image Number 12 for United States Patent #8372983.

Provided herein are novel compounds that inhibit ribonucleotide reductase (RR) by binding to RRM2 and interfering with the activity of the RRM1/RRM2 holoenzyme, as well as methods of synthesizing these novel compounds. The compounds may be used to inhibit RR activity and to treat various conditions associated with RRM2 expression, such as for example certain cancer types, mitochondrial diseases, or degenerative diseases.

  Recently Added Patents
Distortion estimation for quantized data
Electrical stimulation lead, system, and method
Using storage cells to perform computation
Bull stationery tab
High-density 3-dimensional structure
Mobile device case with storage compartment
Key management system
  Randomly Featured Patents
Photographic lighting apparatus
Pocket electronic dictionary
Ultraviolet transmitting multi-layer polarizer
Systems and methods for determining an operating state using RFID
Communication methods and terminals for improving the transfer of connection between cells belonging to different networks
Self-crosslinkable resin
Systems, methods, apparatuses, and computer program products for supporting remote hosting without using network address translation
Method for performing multiplex PCR with cyclic changes of PCR parameters
Process and installation for the separation of air
Detachable belt clip interface mechanism for phone holsters and wireless phone holster assembly